RogCon's Unattributed Round

RogCon raised a round of funding on April 03, 2017.

RogCon is a biotechnology company focused on drug research, discovery and development for select ion channelopathies, with a primary focus on SCN2A.…

Articles about RogCon's Unattributed Round: